Cite

HARVARD Citation

    Enomoto, Y. et al. (2017). Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease. Arthritis research & therapy. 19 (1), pp. 1-9. [Online]. 
  
Back to record